ABSTRACT
Background Acute traumatic spinal cord injury (SCI) induces a systemic immune response involving circulating white blood cells (WBC). How this response is influenced by overall trauma severity, the neurological level of injury and/or correlates with patient outcomes is poorly understood. The objective of this study was to identify relationships between early changes in circulating WBCs, injury characteristics, and long-term patient outcomes in individuals with traumatic SCI.
Methods We retrospectively analysed data from n=161 SCI patients admitted to Brisbane’s Princess Alexandra Hospital (exploration cohort). Logistic regression models in conjunction with receiver-operator characteristic (ROC) analyses were used to assess the strength of specific links between the WBC response, respiratory infection incidence and neurological outcomes (American Spinal Injury Association Impairment Scale (AIS) grade conversion). An independent validation cohort from the Trauma Hospital Berlin, Germany (n=49) was then probed to assess the robustness of effects and to disentangle centre effects.
Results We find that the extent of acute neutrophilia in human SCI patients is positively correlated with New Injury Severity Scores (NISS) but inversely with the neurological outcome (AIS grade). Multivariate analysis demonstrated that acute SCI-induced neutrophilia is an independent predictor of AIS grade conversion failure, with an odds ratio (OR) of 4.16 and ROC area under curve (AUC) of 0.82 (p<0.0001). SCI-induced lymphopenia was separately identified as an independent predictor of better recovery (OR = 24.15; ROC AUC = 0.85, p<0.0001). Acute neutrophilia and increased neutrophil-lymphocyte ratios were otherwise significantly associated with respiratory infection presentation in both patient cohorts.
Conclusions Our findings demonstrate the prognostic value of modelling early circulating neutrophil and lymphocyte counts with patient characteristics for predicting the longer-term recovery after SCI.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Work in the laboratory of M.J.R. was made possible by SpinalCure Australia. T.J. was additionally supported by a Research Training Program Scholarship (Australian Government). J.M.S. was supported by the National Institute of Disability, Independent Living and Rehabilitation Research (NIDILRR Grant 90SI5020), the National Institutes of Neurological Disorders-NIH (Grant R01 NS118200-01), the European Union (EU Era Net - Neuron Program, SILENCE Grant 01EW170A), the Craig H Neilsen Foundation (Grant 596764), the Wings for Life Foundation and the William E. Hunt and Charlotte M. Curtis endowment (to J.M.S.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Human Research Ethics Committee for Metro South Health (HREC/16/QPAH/196) and ratified by The University of Queensland (HREC 2014000031) Human Research Ethics Committee of Charité-Universitätsmedizin Berlin (#EA2/015/15 and #EA1/001/09)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
FUNDING Work in the laboratory of M.J.R. was made possible by SpinalCure Australia. T.J. was additionally supported by a Research Training Program Scholarship (Australian Government). J.M.S. was supported by the National Institute of Disability, Independent Living and Rehabilitation Research (NIDILRR Grant 90SI5020), the National Institutes of Neurological Disorders-NIH (Grant R01 NS118200-01), the European Union (EU Era Net – Neuron Program, SILENCE Grant 01EW170A), the Craig H Neilsen Foundation (Grant 596764), the Wings for Life Foundation and the William E. Hunt and Charlotte M. Curtis endowment (to J.M.S.).
Funding disclosures: All authors report no funding disclosures.
Data Availability
Requests for access to study data should be directed to the corresponding authors for consideration, and can be provided pending appropriate institutional review board approvals.
ABBREVIATIONS
- AIS
- American Spinal Injury Association Impairment Scale
- ANOVA
- analysis of variance
- ASIA
- American Spinal Injury Association
- AUC
- area under the curve
- BMI
- body mass index
- C1-8
- cervical vertebra 1-8
- CDC
- Centres for Disease Control and Prevention
- COaT-SCI
- Comparative Outcome And Treatment Evaluation in Spinal Cord Injury
- dpi
- days post-injury
- ICU
- intensive care unit
- IQR
- interquartile range
- ISNCSCI
- International Standards for Neurological Classification of Spinal Cord injury
- MT
- multi-trauma
- NISS
- new injury severity score
- OR
- odds ratio
- PAH
- Princess Alexandra Hospital
- ROC
- receiver operator characteristic
- SCI
- spinal cord injury
- SCI-IDS
- spinal cord injury-induced immune depression syndrome
- SIRS
- systemic inflammatory response syndrome
- T1-12
- thoracic vertebra 1-12
- WBC
- white blood cell
